Continuing Medical EducationPsoriasis of the nail: Anatomy, pathology, clinical presentation, and a review of the literature on therapy
Section snippets
The nail
Over the years, a number of sources have extensively described the anatomic, embryologic, and clinical aspects of nail disease. Baran and Dawber,10 Scher and Daniel,11 and Samman and Fenton9 have provided excellent resources that were used throughout this article. However, the majority of the information regarding the various aspects of the nail unit was attained from the publications of Zaias,12, 13, 14, 15 whose work on nails is among the most comprehensive within the current literature.
Embryology
The earliest signs of cellular growth and differentiation related to nail development are seen as early as 8 weeks' gestation. The first anatomically recognizable feature, however, is visible at 9 weeks' gestation.12 At this early age, an invagination of the primitive epidermis forms an uninterrupted groove that delineates a flattened surface at the end of each digit, known as the nail field (Fig 3).
At 11 weeks, the proximal nail field displays the beginnings of a structure known as the matrix
Immunology of psoriasis
Historically, psoriasis was considered to be an abnormal proliferation and differentiation of keratinocytes. However, the discovery that patients with psoriasis who underwent organ transplantation and subsequently received cyclosporine A to prevent graft rejection showed improvement in their skin disease was the first indication that psoriasis was a disease of immunology as opposed to abnormal keratinization.19 Ensuing studies using cyclosporine20 and denileukin difitox21, 22 to treat
Treatment
Although there have been many recent advances in the treatment of skin psoriasis, the options for nail psoriasis are far more limited in scope and efficacy. The general paucity of well-documented clinical studies makes it difficult to select an ideal therapy, because the current modalities are often tedious to administer with short-lived remissions. Nail psoriasis tends to be persistent and refractory to treatment, and so it is understandable that a standardized therapeutic regimen does not
Conclusions and future trends
As nail psoriasis is one of the lesser-studied disorders within the field of dermatology, its treatment still remains relatively ambiguous. With a lifetime incidence of 80% to 90% amongst psoriatics,9 it remains an often overlooked yet important aspect of psoriasis treatment. Although the therapeutic options for skin psoriasis are considerably broader and far more proven than those for nail disease, several treatment alternatives still exist. However, the scarcity of well-documented evidence
References (127)
Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment
Dermatol Clin
(1996)The formation of the primate nail: an autoradiographic study
J Invest Dermatol
(1968)Drug delivery to the nail following topical application
Int J Pharm
(2002)- et al.
Administration of DAB389IL-2 to patients with recalcitrant psoriasis: a double-blind, phase II multicenter trial
J Am Acad Dermatol
(1998) Psoriasis
Lancet
(2003)- et al.
Interaction of T cells with APCs—the serial encounter model
Trends Immunol
(2001) - et al.
Mechanisms of glucocorticoid hormone action
J Steroid Biochem
(1984) - et al.
Growth hormone gene transcription is regulated by thyroid and glucocorticoid hormones in cultured rat pituitary tumor cells
J Biol Chem
(1982) - et al.
A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses
J Am Acad Dermatol
(1999) - et al.
Chemotherapy for disseminated actinic keratoses with 5-fluorouracil and isotretinoin
J Am Acad Dermatol
(1997)
Weekly pulse dosing: effective and comfortable topical 5-fluorouracil treatment of multiple facial actinic keratoses
J Am Acad Dermatol
Inhibition of a Langerhans cell-mediated immune response by treatment modalities useful in psoriasis
J Invest Dermatol
Tazarotene combination treatments in psoriasis
J Am Acad Dermatol
Tazarotene plus UVB phototherapy in the treatment of psoriasis
J Am Acad Dermatol
Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis
J Am Acad Dermatol
The mechanism of action of cyclosporine and FK506
Immunol Today
Calcineurin is a common target of cyclophilin-cyclosporin and FKPP-FK5-6 complexes
Cell
Cyclosporin A inhbits the production of gamma interferon (IFN-γ), but does not inhibit production of virus-induced IFN-γ
Cell Immunol
Psoriasis of the nails
Arch Derm Syphilol
The nails in psoriatic arthritis
Br J Dermatol
Psoriasis and the nails
Br J Dermatol
Die krankheiten der nagel
The nails in disease, 5th ed
Diseases of the nail and their management
Nails: therapy, diagnosis, surgery
The nail in health and disease, 2nd ed
Psoriasis of the nail: a clinical-pathologic study
Arch Dermatol
The embryology of the human nail
Arch Dermatol
The normal and pathologic nail
Int J Dermatol
A text atlas of nail disorders. Techniques in investigation and diagnosis, 3rd ed
Cyclosporin A for psoriasis
N Engl J Med
Cyclosporine improves psoriasis in a double-blind study
JAMA
Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis
Nat Med
The immunologic basis for the treatment of psoriasis with new biologic agents
J Am Acad Dermatol
The immunology of psoriasis and biologic immunotherapy
J Am Acad Dermatol
Psoriasis and the new biologic agents: interrupting a T-AP dance
CMAJ
Pathophysiology of psoriasis: science behind therapy
J Cutan Med Surg
T lymphocyte activation—an inside overview
Acta Med Austriaca
Intercellular transfer of antigen-presenting cell determinants onto T cells—molecular mechanisms and biological significance
FASEB J
Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells
Nature
ELAM-1 is an adhesion molecule for skin-homing T cells
Nature
Clinical observations on nail changes in psoriasis
Ann Acad Med Singapore
Color atlas & synopsis of clinical dermatology, 4th ed
Recurrent atraumatic subungual splinter hemorrhages in healthy individuals
South Med J
Hormone action: control of target cell function by peptide, thyroid and steroid hormones
Glucocorticoid and thyroid hormones transcriptionally regulate growth hormone gene expression
Proc Natl Acad Sci U S A
Comparison of agents producing a neutrophilic leukocytosis in man. Hydrocortisone, prednisone, endotoxin, and etiocholanolone
J Clin Invest
Cited by (0)
Funding source: None.
Conflicts of interest: None declared.
Presented at the 13th Annual European Academy of Dermatology & Venereology Annual Meeting, November 12-13, 2004, Manchester, UK.
Reprints not available from the authors.